Skeletal-related events due to bone metastases from differentiated thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages 2433-2439

  Farooki, Azeez ^a   Leung, Vivien ^b   Tala, Hernan ^c   Tuttle, R Michael ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BRONX LEBANON HOSPITAL CENTER   (United States)

^c UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BONE RADIOGRAPHY; BRAIN METASTASIS; CANCER CENTER; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; ELECTRONIC MEDICAL RECORD; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; MUSCLE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN METASTASIS; SPINAL CORD COMPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE DISEASES; BONE NEOPLASMS; CARCINOMA; CELL DIFFERENTIATION; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84863599516     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1169     Document Type: Article

References (20)

1. Muresan MM, Olivier P, Leclère J, Sirveaux F, Brunaud L, Klein M, Zarnegar R, Weryha G 2008 Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer 15:37-49 (Pubitemid 351449726)
2. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M 2006 Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91:2892-2899 (Pubitemid 44271732)
3. Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM, Robbins RJ 2000 Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid 10:261-268 (Pubitemid 30202413)
4. Coleman RE 2004 Bisphosphonates: clinical experience. Oncologist 9:14-27 (Pubitemid 39363165)
5. Orita Y, Sugitani I, Toda K, Manabe J, Fujimoto Y 2011 Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. Thyroid 21:31-35
6. Coleman RE 2006 Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s-6249s (Pubitemid 44703797)
7. Lipton A, Theriault RL, Hortobagyi GN, Simeone J, Knight RD, Mellars K, Reitsma DJ, Heffernan M, Seaman JJ 2000 Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast cancer and osteolytic bone metastases: longterm results of two randomised, placebo-controlled trials. Cancer 88:1082-1090 (Pubitemid 30127670)
8. Van Poznak CH, Temin S, Yee GC, Janjan NA, Barlow WE, Biermann JS, Bosserman LD, Geoghegan C, Hillner BE, Theriault RL, Zuckerman DS, Von Roenn JH 2011 American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. J Clin Oncol 29:1221-1227
9. Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar RN, Shapiro CL, Shields A, Smith MR, Srinivas S, Van Poznak CH 2009 NCCN task force report: bone health in cancer care. J Natl Compr Canc Netw 7(Suppl 3):S1-S32
10. Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein MA, Coleman RE, Reitsma DJ, Chen BL, Seaman JJ 2003 Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in treatment of skeletal complications in patients with advanced multiple myeloma or breast cancer: a randomized, double-blind, multicenter, comparative trial. Cancer 98:1735-1744 (Pubitemid 37238631)
11. Kohno N, Aogi K, Minami H, Nakamura S, Asaga T, Iino Y, Watanabe T, Goessl C, Ohashi Y, Takashima S 2005 Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol 23:3314-3321
12. Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M, Fan M, Jiang Q, Dansey R, Jun S, Braun A 2010 Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 28:5132-5139
13. Fizazi K, Carducci M, Smith M, Damião R, Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H, Jiang Q, Tadros S, Dansey R, Goessl C 2011 Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 377:813-822
14. Vitale G, Fonderico F, Martignetti A, Caraglia M, Ciccarelli A, Nuzzo V, Abbruzzese A, Lupoli G 2001 Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer 84:1586-1590 (Pubitemid 32612487)
15. Orita Y, Sugitani I, Toda K, Manabe J, Fujimoto Y 2011 Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. Thyroid 1:31-35
16. Rosen LS, Gordon D, Tchekmedyian NS, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, De Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman J 2004 Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial. Cancer 100:2613-2621 (Pubitemid 38715767)
17. Diel IJ, Body JJ, Lichinitser MR, Kreuser ED, Dornoff W, Gorbunova VA, Budde M, Bergström B 2004 Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer. Eur J Cancer 40:1704-1712 (Pubitemid 38902906)
18. Body JJ, Diel IJ, Bell R, Pecherstorfer M, Lichinitser MR, Lazarev AF, Tripathy D, Bergström B 2004 Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer. Pain 111:306-312 (Pubitemid 39201152)
19. Grewal RK, Tuttle RM, Fox J, Borkar S, Chou JF, Gonen M, Strauss HW, Larson SM, Schöder H 2010 The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer. J Nucl Med 51:1361-1367
20. Puhaindran ME, Farooki A, Steensma MR, Hameed M, Healey JH, Boland PJ 2011 Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates. J Bone Joint Surg Am 93:1235-1242